Radiation therapy in the treatment of lung cancer. Hayakawa K. Nippon Igaku Hoshasen Gakkai Zasshi . 2003Hayakawa K.Radiation therapy in the treatment of lung cancer.Nippon Igaku Hoshasen Gakkai Zasshi. 2003Hayakawa K. Radiation therapy in the treatment of lung cancer[J].Nippon Igaku Hoshssen ...
Non-small-cell lung cancer: should unresectable stage 111patients routinely receive high-dose radiation therapy? Clin Oncol 1988; 6:552-8. 4. Johnson DH, Einhorn LH, Bartolucci A, Birch R, Omura G, Perez CA, et al. Thoracicradiotherapy does not prolong survival in patients with locally ...
The purpose of this study as to determine the impact of overall treatment time on long-term survival after high-dose radiation therapy alone for inoperable non-small cell lung cancer (NSCLC). Between 1978 and 1990, 229 patients with stag... H Willers,F Würschmidt - 《Acta Oncologica》 被...
Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancerResults: The objective response rate was 69.4% (complete response: 26.5%, 13/49; partial response: 42.9%, 21/49) and median survival was 22 months. The 1-year,...
This cohort study examines the overall survival in men with very high-risk prostate cancer who are treated with radiotherapy and hormone therapy at
"The Radiation Therapy Oncology Group (RTOG) was initially organized in 1968 under the direction of Dr. Simon Kramer as a national cooperative group for the purpose of conducting radiation therapy research and clinical investigations. Funding from the National Cancer Institute (NCI) began in 1971. ...
Radiotherapy is one of the most effective approaches to achieve tumor control in cancer patients, although healthy tissue injury due to off-target radiation exposure can occur. In this study, we used a model of acute radiation injury to the lung, in the
C. et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat. Med. 24, 1845–1851 (2018). Article CAS PubMed PubMed Central Google Scholar Kroemer, G., Galluzzi, L., Kepp, O. & Zitvogel, L. Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31, ...
Whole brain radiotherapy for brain metastases from non-small lung cancer: Quality of life (QoL) and overall survival (OS) results from the UK Medical Research Council QUARTZ randomised clinical trial (ISRCTN 3826061). Whole brain radio- therapy for brain metastases from non-small lung cancer: Qua...
= fractions; IMRT = intensity modulated radiation therapy; KQs = key questions; LS = limited-stage; MRI = magnetic resonance imaging; OS = overall survival; PCI = prophylactic cranial irradiation; RT = radiation therapy; SBRT = stereotactic body radiation therapy; SCLC = small cell lung cancer...